Cogent Biosciences
NASDAQ:COGT
Develops targeted therapies for oncology.
Develops targeted therapies for oncology.
Sector
Life SciencesCategory
TherapeuticsLocation
Cambridge, MAInitial Investment
2014
Cogent Biosciences (NASDAQ:COGT) (formerly Unum Therapeutics) is developing precision therapies for genetically defined diseases with a clinical stage therapy for systemic mastocytosis.